Medicare Enrolled

Dr. Farah Smith, NP-C

Nurse Practitioner - Family · Douglas, GA
Low-engagement
300 SHIRLEY AVE, Douglas, GA 31533
9123847275
In practice since 2016 (10 years)
NPI: 1447616461 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Smith

Dr. Farah Smith is a nurse practitioner - family in Douglas, GA, with 10 years of NPI registration.

Between the years covered by Open Payments, Dr. Smith received a total of $12,128 from 52 pharmaceutical and/or device companies across 602 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Smith is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice $12,128 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,128
Total received (2021-2024)
Avg $3,032/year across 4 years
Top 1% in GA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
602
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,914 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$214 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,835
2023
$3,453
2022
$2,969
2021
$2,870

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$385
ABBVIE INC.
$305
Daiichi Sankyo Inc.
$268
Novo Nordisk Inc
$231
AstraZeneca Pharmaceuticals LP
$230
PFIZER INC.
$228
GlaxoSmithKline, LLC.
$196
Amgen Inc.
$131
Alkermes, Inc.
$120
ABIOMED
$98
Otsuka America Pharmaceutical, Inc.
$95
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$84
Sumitomo Pharma America, Inc.
$66
Lundbeck LLC
$55
Axsome Therapeutics, Inc.
$54
Exact Sciences Corporation
$37
Lilly USA, LLC
$31
Dexcom, Inc.
$31
E.R. Squibb & Sons, L.L.C.
$28
Astellas Pharma US Inc
$21
Antares Pharma, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Philips North America LLC
$18
Abbott Laboratories
$18
AIMMUNE THERAPEUTICS, INC.
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
IDORSIA PHARMACEUTICALS US INC
$16
Mylan Specialty L.P.
$16
Top 3 companies account for 33.8% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$1,108
Amgen Inc.
$841
GlaxoSmithKline, LLC.
$833
PFIZER INC.
$819
ABBVIE INC.
$799
Corcept Therapeutics
$730
Astellas Pharma US Inc
$710
AstraZeneca Pharmaceuticals LP
$559
Daiichi Sankyo Inc.
$552
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$493
AbbVie Inc.
$468
Otsuka America Pharmaceutical, Inc.
$432
Sunovion Pharmaceuticals Inc.
$261
Janssen Pharmaceuticals, Inc
$234
Mylan Specialty L.P.
$229
Esperion Therapeutics, Inc.
$192
Novartis Pharmaceuticals Corporation
$187
Sumitomo Pharma America, Inc.
$181
Bayer Healthcare Pharmaceuticals Inc.
$180
Electromed, Inc.
$151
Organogenesis Inc.
$149
Lilly USA, LLC
$141
Nestle HealthCare Nutrition Inc.
$133
Biohaven Pharmaceuticals, Inc.
$129
Horizon Therapeutics plc
$125
UROVANT SCIENCES INC
$125
Alkermes, Inc.
$120
Biohaven Pharmaceutical Holding Company Ltd.
$107
ABIOMED
$98
Merck Sharp & Dohme LLC
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
IDORSIA PHARMACEUTICALS US INC
$78
Antares Pharma, Inc.
$74
Bayer HealthCare Pharmaceuticals Inc.
$73
Lundbeck LLC
$55
Axsome Therapeutics, Inc.
$54
OPKO Pharmaceuticals, LLC
$52
Kowa Pharmaceuticals America, Inc.
$51
Supernus Pharmaceuticals, Inc.
$47
Abbott Laboratories
$44
Boston Scientific Corporation
$43
SANOFI PASTEUR INC.
$39
Amarin Pharma Inc.
$37
Exact Sciences Corporation
$37
Merck Sharp & Dohme Corporation
$37
Dexcom, Inc.
$31
E.R. Squibb & Sons, L.L.C.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$23
Philips North America LLC
$18
AIMMUNE THERAPEUTICS, INC.
$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$17
Regeneron Healthcare Solutions, Inc.
$14
Top 3 companies account for 22.9% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · AIRSUPRA · APTIOM · AREXVY · Aimovig · Auvelity · BELSOMRA · BREZTRI · CAMZYOS · CAPLYTA · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · DUPIXENT · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · General - Polypectomy · INJECTAFER · Impella · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LINZESS · LONHALA MAGNAIR · LYBALVI · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PREVNAR 20 · Prolia · Puraply · Puraply Antimicrobial · QULIPTA · QUVIVIQ · RAYALDEE · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SMARTVEST · STEGLATRO · Saxenda · TLANDO · TRELEGY ELLIPTA · TRINTELLIX · UBRELVY · VERQUVO · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · XYOSTED · YUPELRI · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in GA.

Looking for a nurse practitioner - family in Douglas?
Compare family nurse practitioners in the Douglas area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
86
Per 100K population
199.3
County median income
$50,175
Nearest hospital
COFFEE REGIONAL MEDICAL CENTER, INC
21.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Smith is a nurse practitioner - family, with low-engagement industry engagement in the top 1% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $12,128 from 52 companies across 602 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Douglas
Browse family nurse practitioners in Douglas ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in GA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in GA
Which GA family nurse practitioners receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →